Element Capital Management LLC Infla Rx N.V. Transaction History

Element Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$23.33 - $36.37 $148,122 - $230,913	-6,349 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.34 - $35.0 $19,540 - $23,310	-666 Reduced 9.49%	6,349 $218,000
Q2 2018 Aug 14, 2018	BUY	$27.33 - $41.46 $191,719 - $290,841	7,015 New	7,015 $226,000

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.